Hadassah's Fertility Expert Caters to Hopeful Potential Parents with New Clinic
Despite advances in fertility, many live with the pain of unfilled dreams of parenthood.
Last week, Hadassah Medical Organization's fertility expert Prof. Ariel Revel met a large crowd of potential parents in Tel Aviv at an open meeting where he and other physicians from Hadassah along with colleagues from the Czech Republic revealed how a successful program has been able to overcome one of the common barriers in fertility: the need for egg donation.
Israel's Knesset has passed a law legalizing egg donation, but in practical terms, the supply of donor eggs in Israel is so small most Israelis cannot find a donor.
Prof. Revel has created a program where each potential parent or couple receives personalized care, including emotional support and the most advanced technology. Hadassah works together with a well-regulated Czech Republic clinic which has an abundant supply of donor eggs. The process can be coordinated with Jerusalem's Puah Institute to respect stringent Jewish religious requirements for patients who desire.
The experienced and advanced Hadassah team handles all medical and logistics issues, while providing guidance and support to the couple.
To make the process easier for those who live in Israel's populous coastal region, Prof. Revel and his staff have opened a Hadassah clinic in Tel Aviv.
Said one woman who attended the Tel Aviv open-house,
"Frankly, I came to the evening with the feeling that I was joining a group of losers. But Dr. Revel made me feel that there were new possibilities and that I would receive a helping hand in undergoing a new approach to a part of my life that has been full of pain. I'm going to give it a try with Hadassah."
The OB/GYN floor of the Charlotte R. Bloomberg Mother & Child Center at Hadassah University Medical Center in Ein Kerem combines comfort and intimacy with state-of-the- art technology.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>